| |
| |
|
| Insider
Information: |
Abbey Jeffrey D |
| Relationship: |
Chief Executive Office... |
| City: |
Durham |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
25,450 |
|
|
Indirect Shares
|
11,500 |
|
|
| Direct
Value |
$1,363 |
|
|
|
Indirect Value
|
$616 |
|
|
| Total
Shares |
36,950 |
|
|
| Total
Value |
$1,979 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Argos Therapeutics Inc |
ARGS |
Chief Executive Office... |
2018-04-25 |
25,450 |
2015-12-14 |
11,500 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARGS |
Argos Therapeutics Inc |
Chief Executive Officer |
• • – |
2018-04-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(67,887) |
25,450 |
0 |
- |
|
| ARGS |
Argos Therapeutics Inc |
Chief Executive Officer |
• • – |
2018-03-28 |
4 |
A |
$0.00 |
$0 |
D/D |
67,887 |
93,337 |
0 |
- |
|
| ARGS |
Argos Therapeutics Inc |
President, CEO |
• • – |
2018-01-10 |
4/A |
AS |
$0.16 |
$20,573 |
D/D |
(124,987) |
510,046 |
0 |
- |
|
| ARGS |
Argos Therapeutics Inc |
President, CEO |
• • – |
2018-01-09 |
4 |
AS |
$0.16 |
$20,573 |
D/D |
(124,987) |
510,046 |
0 |
- |
|
| ARGS |
Argos Therapeutics Inc |
President, CEO |
• • – |
2018-01-03 |
4 |
AS |
$0.16 |
$18,719 |
D/D |
(114,702) |
635,033 |
0 |
- |
|
| ARGS |
Argos Therapeutics Inc |
Chief Executive Officer |
• • – |
2017-08-30 |
4 |
A |
$0.00 |
$0 |
D/D |
622,685 |
749,735 |
0 |
- |
|
| ARGS |
Argos Therapeutics Inc |
Chief Executive Officer |
• • – |
2017-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
17,430 |
127,050 |
0 |
- |
|
| ARGS |
Argos Therapeutics Inc |
Chief Executive Officer |
• • – |
2016-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
10,924 |
109,620 |
0 |
- |
|
| ARGS |
Argos Therapeutics Inc |
CEO |
• • – |
2016-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
90,401 |
96,694 |
0 |
- |
|
| ARGS |
Argos Therapeutics Inc |
CEO |
• • – |
2015-12-14 |
4/A |
B |
$2.50 |
$12,486 |
I/I |
5,000 |
11,500 |
2.58 |
- |
|
| ARGS |
Argos Therapeutics Inc |
CEO |
• • – |
2015-12-14 |
4 |
B |
$2.50 |
$12,486 |
I/I |
5,000 |
10,500 |
2.58 |
- |
|
| ARGS |
Argos Therapeutics Inc |
CEO |
• • – |
2015-12-02 |
4 |
B |
$3.89 |
$3,889 |
D/D |
1,000 |
6,293 |
2.73 |
- |
|
| ARGS |
Argos Therapeutics Inc |
CEO |
• • – |
2015-11-19 |
4 |
B |
$4.08 |
$4,080 |
I/I |
1,000 |
6,500 |
2.58 |
- |
|
| ARGS |
Argos Therapeutics Inc |
CEO |
• • – |
2015-08-19 |
4 |
B |
$4.75 |
$26,149 |
I/I |
5,500 |
5,500 |
2.66 |
- |
|
| ARGS |
Argos Therapeutics Inc |
Chief Executive Officer |
• • – |
2014-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,580 |
2,580 |
0 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
